Table 2 Baseline and clinical characteristics of subjects with bronchiectasis, with and without cardiovascular disease
From: Clinical impact of cardiovascular disease on patients with bronchiectasis
Parameter | Bronchiectasis (n = 404) | Bronchiectasis with cardiovascular disease (n = 199) | P-value |
|---|---|---|---|
Age, years | 61.97 ± 11.17 | 65.35 ± 9.75 | 0.107 |
Sex male: female n | 191:213 | 80:119 | 0.1 |
BMI, kg/m2 | 23.81 ± 3.45 | 23.51 ± 3.22 | 0.591 |
Smoking | 17.6% | 16.6% | 0.762 |
Previous pneumonia | 38.9% | 33.2% | 0.173 |
Previous tuberculosis | 12.4% | 20.6% | 0.008 |
Previous anaphylactic rhinitis | 2.2% | 1.5% | 0.552 |
Presenting symptoms | |||
 Cough | 70.3% | 73.4% | 0.433 |
 Wheezing | 51.2% | 65.3% | 0.001 |
 Hemoptysis | 44.6% | 34.7% | 0.02 |
P.aeruginosa isolation | 22.8% | 30.2% | 0.063 |
Type | |||
 Cylindrical | 28.2% | 22.6% | 0.142 |
 Cystic | 35.1% | 40.7% | 0.184 |
 Mixed | 36.6% | 36.7% | 0.99 |
Location | |||
 Unilateral | 25.0% | 26.1% |  |
 Bilateral | 75.0% | 73.9% | 0.764 |
Extent | |||
 Affected lobes n | 3.21 ± 1.47 | 3.12 ± 1.43 | 0.465 |
 Affected segments n | 8.50 ± 5.15 | 8.71 ± 4.70 | 0.011 |